Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...
HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...
The UK has approved a long-acting HIV jab that requires just one injection every two months. Doctors call it a breakthrough ...
Researchers at UVA School of Medicine have found long-sought answers to questions about HIV transmission, and the findings could lead to new ways to prevent the disease’s spread. More than 1 million ...
Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...
Morning Overview on MSN
Researchers make major progress toward curing HIV
On October 20, 2025, scientists announced a significant advancement toward curing HIV, marking a pivotal moment in the ...
KANSAS CITY, Mo. — National Women and Girls HIV/AIDS Awareness Day is recognized March 10. Kansas City nonprofit BlaqOut, which works to improve healthcare access while creating a safe space for KC's ...
allAfrica.com on MSN
SA becomes the first African country to register the twice-a-year anti-HIV jab — at record speed
South Africa has become the first African country — and our medicines regulator the third worldwide — to register the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results